Zura Bio (ZURA) Competitors $2.20 -0.31 (-12.35%) (As of 12/12/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZURA vs. ESPR, ANAB, CGEM, DNTH, TECX, STOK, AVXL, ABUS, ALT, and ORICShould you be buying Zura Bio stock or one of its competitors? The main competitors of Zura Bio include Esperion Therapeutics (ESPR), AnaptysBio (ANAB), Cullinan Therapeutics (CGEM), Dianthus Therapeutics (DNTH), Tectonic Therapeutic (TECX), Stoke Therapeutics (STOK), Anavex Life Sciences (AVXL), Arbutus Biopharma (ABUS), Altimmune (ALT), and ORIC Pharmaceuticals (ORIC). These companies are all part of the "pharmaceutical products" industry. Zura Bio vs. Esperion Therapeutics AnaptysBio Cullinan Therapeutics Dianthus Therapeutics Tectonic Therapeutic Stoke Therapeutics Anavex Life Sciences Arbutus Biopharma Altimmune ORIC Pharmaceuticals Zura Bio (NASDAQ:ZURA) and Esperion Therapeutics (NASDAQ:ESPR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership. Do insiders & institutionals believe in ZURA or ESPR? 61.1% of Zura Bio shares are held by institutional investors. Comparatively, 47.4% of Esperion Therapeutics shares are held by institutional investors. 22.1% of Zura Bio shares are held by insiders. Comparatively, 1.0% of Esperion Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is ZURA or ESPR more profitable? Zura Bio has a net margin of 0.00% compared to Esperion Therapeutics' net margin of -29.37%. Esperion Therapeutics' return on equity of 0.00% beat Zura Bio's return on equity.Company Net Margins Return on Equity Return on Assets Zura BioN/A -37.36% -29.81% Esperion Therapeutics -29.37%N/A -10.77% Do analysts recommend ZURA or ESPR? Zura Bio presently has a consensus price target of $15.80, suggesting a potential upside of 628.11%. Esperion Therapeutics has a consensus price target of $8.17, suggesting a potential upside of 212.90%. Given Zura Bio's stronger consensus rating and higher probable upside, equities analysts clearly believe Zura Bio is more favorable than Esperion Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zura Bio 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00Esperion Therapeutics 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media prefer ZURA or ESPR? In the previous week, Esperion Therapeutics had 5 more articles in the media than Zura Bio. MarketBeat recorded 7 mentions for Esperion Therapeutics and 2 mentions for Zura Bio. Esperion Therapeutics' average media sentiment score of 0.82 beat Zura Bio's score of 0.44 indicating that Esperion Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Zura Bio Neutral Esperion Therapeutics Positive Which has more risk and volatility, ZURA or ESPR? Zura Bio has a beta of -0.02, suggesting that its stock price is 102% less volatile than the S&P 500. Comparatively, Esperion Therapeutics has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Does the MarketBeat Community favor ZURA or ESPR? Esperion Therapeutics received 599 more outperform votes than Zura Bio when rated by MarketBeat users. However, 82.61% of users gave Zura Bio an outperform vote while only 69.99% of users gave Esperion Therapeutics an outperform vote. CompanyUnderperformOutperformZura BioOutperform Votes1982.61% Underperform Votes417.39%Esperion TherapeuticsOutperform Votes61869.99% Underperform Votes26530.01% Which has better earnings & valuation, ZURA or ESPR? Zura Bio has higher earnings, but lower revenue than Esperion Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZura BioN/AN/A-$69.24MN/AN/AEsperion Therapeutics$295.45M1.74-$209.25M-$0.64-4.08 SummaryZura Bio beats Esperion Therapeutics on 9 of the 16 factors compared between the two stocks. Ad Brownstone ResearchVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up to a location just a few miles from here to show you Elon Musk’s next AI product. I promise what happens next will shock you…”Click here to see what happened Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZURA vs. The Competition Export to ExcelMetricZura BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$141.68M$2.98B$5.18B$9.22BDividend YieldN/A1.85%5.12%3.95%P/E RatioN/A46.12131.6417.52Price / SalesN/A441.871,300.26128.39Price / CashN/A178.4835.6035.66Price / Book1.173.944.754.91Net Income-$69.24M-$41.90M$118.27M$224.68M7 Day Performance-22.50%1.35%-0.02%0.41%1 Month Performance-52.10%-3.06%-1.91%3.88%1 Year Performance-49.18%30.26%31.67%27.58% Zura Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZURAZura Bio3.1348 of 5 stars$2.20-12.4%$15.80+618.2%-48.5%$143.64MN/A0.003Analyst ForecastHigh Trading VolumeESPREsperion Therapeutics3.9946 of 5 stars$3.82+9.8%$8.17+113.8%+73.5%$752.69M$116.33M-5.97240Analyst ForecastANABAnaptysBio2.2426 of 5 stars$24.59-0.9%$54.64+122.2%-12.4%$748.27M$17.16M0.00100Analyst DowngradeShort Interest ↑CGEMCullinan Therapeutics1.6289 of 5 stars$12.84-1.7%$31.67+146.6%+54.6%$747.67M$18.94M-4.5330Short Interest ↑DNTHDianthus Therapeutics1.6847 of 5 stars$24.92+2.2%$46.43+86.3%+200.5%$737.63M$2.83M0.0080Positive NewsTECXTectonic Therapeutic3.2519 of 5 stars$49.55-3.7%$72.25+45.8%N/A$730.86MN/A0.00120Positive NewsSTOKStoke Therapeutics4.1149 of 5 stars$13.45+1.4%$20.83+54.9%+149.9%$712.45M$8.78M0.00100Analyst ForecastInsider TradeNews CoverageAVXLAnavex Life Sciences3.5315 of 5 stars$8.34+2.5%$43.00+415.6%+5.2%$707.23MN/A0.0040ABUSArbutus Biopharma2.1738 of 5 stars$3.70+0.5%$5.50+48.6%+73.7%$701.11M$18.14M0.0073ALTAltimmune2.1008 of 5 stars$9.68+6.3%$20.00+106.6%+44.6%$688.44M$430,000.000.0050ORICORIC Pharmaceuticals3.9241 of 5 stars$9.62-2.8%$18.29+90.1%-2.5%$678.88MN/A0.0080Positive News Related Companies and Tools Related Companies ESPR Alternatives ANAB Alternatives CGEM Alternatives DNTH Alternatives TECX Alternatives STOK Alternatives AVXL Alternatives ABUS Alternatives ALT Alternatives ORIC Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZURA) was last updated on 12/13/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zura Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZURA Stock Alerts